πŸ‡ΊπŸ‡Έ FDA
Patent

US 7678918

Intermediates for imidazonaphthyridines

granted A61KA61K31/4745A61K45/06

Quick answer

US patent 7678918 (Intermediates for imidazonaphthyridines) held by Graceway Pharmaceuticals. LLC expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Graceway Pharmaceuticals. LLC
Grant date
Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/4745, A61K45/06, A61P, A61P11/02